{"id":891636,"date":"2026-10-23T05:58:14","date_gmt":"2026-10-23T05:58:14","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/891636\/"},"modified":"2026-10-23T05:58:14","modified_gmt":"2026-10-23T05:58:14","slug":"a-first-for-crispr-powerful-prime-editing-alters-dna-directly-in-the-human-body","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/891636\/","title":{"rendered":"A first for CRISPR: powerful prime editing alters DNA directly in the human body"},"content":{"rendered":"<p> <img decoding=\"async\" class=\"figure__image\" alt=\"Close-up illustration of a DNA double helix with two highlighted segments and smaller DNA strands in the background\" loading=\"lazy\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/10\/d41586-026-03371-x_53883108.jpg\"\/><\/p>\n<p class=\"figure__caption u-sans-serif\">The method called prime editing can make fine-scale edits to DNA (artist\u2019s illustration).Credit: Patrick Landmann\/Science Photo Library<\/p>\n<p>A powerful <a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03164-5\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-019-03164-5\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">gene-editing technique<\/a> has been used to edit DNA directly in a person\u2019s body \u2014 the first known instance of such a treatment. <\/p>\n<p>The milestone treatment is part of a clinical trial of prime editing, a technique that can alter DNA with more precision than standard CRISPR\u2013Cas9 methods can. In this case, prime editing was used to treat a condition called Wilson disease by rewriting DNA in liver cells, to erase a mutation that prevents them from eliminating excess copper.<\/p>\n<p>Prime Medicine, a biotechnology company in Cambridge, Massachusetts, <a href=\"https:\/\/investors.primemedicine.com\/news-releases\/news-release-details\/prime-medicine-announces-first-patient-dosed-global-phase-12https:\/investors.primemedicine.com\/news-releases\/news-release-details\/prime-medicine-announces-first-patient-dosed-global-phase-12\" data-track=\"click\" data-label=\"https:\/\/investors.primemedicine.com\/news-releases\/news-release-details\/prime-medicine-announces-first-patient-dosed-global-phase-12https:\/investors.primemedicine.com\/news-releases\/news-release-details\/prime-medicine-announces-first-patient-dosed-global-phase-12\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">announced that it had treated the first person<\/a> in its trial earlier this month. It expects to announce the first results from the study next year.<\/p>\n<p><a href=\"https:\/\/www.nature.com\/articles\/d41586-026-02964-w\" class=\"u-link-inherit\" data-track=\"select_article\" data-track-action=\"view recommended article\" data-track-context=\"related article widget on news body\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"recommended__image\" alt=\"\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/10\/d41586-026-03371-x_53887374.jpg\"\/><\/p>\n<p class=\"recommended__title u-serif\">Bigger than CRISPR? A guide to the latest genome editors<\/p>\n<p><\/a><\/p>\n<p>\u201cI never dreamed that in my lifetime I would see this applied to my rare disease,\u201d says Rhonda Rowland, president of the Wilson Disease Association in Atlanta, Georgia. \u201cIt\u2019s going to be a really exciting year.\u201d<\/p>\n<p>In launching the trial, Prime Medicine joins a host of companies aiming to <a href=\"https:\/\/www.nature.com\/articles\/d41586-021-01776-4\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-021-01776-4\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">engineer cells directly in the body<\/a>, rather than using the standard method of extracting a person\u2019s cells, editing their DNA in a laboratory and then reinjecting the altered cells. Rewriting DNA in the body, or in vivo, is appealing because manufacturing and administering the treatment might be much cheaper and faster than making a bespoke therapy for each person from their own cells.<\/p>\n<p>But in vivo approaches have their own challenges, says Krishanu Saha, a biomedical engineer at the University of Wisconsin\u2013Madison. \u201cIt depends on what types of risks you\u2019re willing to accept,\u201d he says.<\/p>\n<p>Prime time<\/p>\n<p>Wilson disease is caused by mutations in a gene called ATP7B, which encodes a protein that transports excess copper out of the liver. If left untreated, the resulting build-up of copper can cause liver and nerve damage, as well as neurological disorders.<\/p>\n<p>People with Wilson disease are eager for a one-and-done treatment for their condition, says Rowland, rather than the current, complicated regimen of copper-clearing molecules and other medicines. And gene editing could, in theory, provide a lasting solution by correcting the faulty ATP7B gene.<\/p>\n<p>So far, the US Food and Drug Administration (FDA) <a href=\"https:\/\/www.nature.com\/articles\/d41586-024-04102-w\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-024-04102-w\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">has approved only one gene-editing therapy<\/a>, called Casgevy, which is used to treat two inherited blood disorders. Casgevy relies on CRISPR\u2013Cas9 gene editing, which is often used to disable genes rather than to rewrite their sequences.<\/p>\n<p><a href=\"https:\/\/www.nature.com\/articles\/d41586-026-02268-z\" class=\"u-link-inherit\" data-track=\"select_article\" data-track-action=\"view recommended article\" data-track-context=\"related article widget on news body\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"recommended__image\" alt=\"\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/10\/d41586-026-03371-x_53021690.jpg\"\/><\/p>\n<p class=\"recommended__title u-serif\">Bizarre CRISPR enzyme kills cancer cells by shredding their DNA<\/p>\n<p><\/a><\/p>\n<p>Another form of <a href=\"https:\/\/www.nature.com\/articles\/d41586-024-04102-w\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-024-04102-w\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">gene editing<\/a>, called base editing, can rewrite individual DNA letters, but cannot make the particular corrections needed to fix the most common ATP7B mutations. That left prime editing, a more complex and versatile system that can insert, delete and rewrite segments of DNA. In <a href=\"https:\/\/www.nature.com\/articles\/d41586-025-01593-z\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-025-01593-z\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">another clinical trial<\/a>, Prime Medicine used the technique to treat two people with a rare immune disorder, by rewriting DNA in each participant\u2019s blood stem cells outside of the body and then injecting them back in.<\/p>\n<p>So far, no gene-editing therapies have been approved for use in vivo. But the FDA is expected to issue a decision early next year about an in vivo CRISPR\u2013Cas9 therapy for a condition called hereditary angioedema, which causes severe swelling.<\/p>\n","protected":false},"excerpt":{"rendered":"The method called prime editing can make fine-scale edits to DNA (artist\u2019s illustration).Credit: Patrick Landmann\/Science Photo Library A&hellip;\n","protected":false},"author":2,"featured_media":891637,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32],"tags":[126735,1159,10545,3625,1160,79],"class_list":["post-891636","post","type-post","status-publish","format-standard","has-post-thumbnail","category-science","tag-crispr-cas9-genome-editing","tag-humanities-and-social-sciences","tag-medical-research","tag-metabolism","tag-multidisciplinary","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/891636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=891636"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/891636\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/891637"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=891636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=891636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=891636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}